GE HealthCare raised its 2026 adjusted earnings forecast on October 28 after reporting higher revenue and profit for the quarter ended September 30, according to its earnings release.
Revenue increased 7.2% to $5.5 billion. On the company's organic basis, sales grew 6.2%. Net income attributable to GE HealthCare rose to $615 million from $446 million a year earlier.
Diluted earnings increased to $1.36 per share from 98 cents. Adjusted earnings were $1.34 per share, compared with $1.07. The company cited volume, pricing, productivity and a favorable net tariff comparison, partly offset by inflation, as drivers of margin improvement.
Sales increased 6.1% in Advanced Imaging Solutions, 13% in Pharmaceutical Diagnostics and 8.5% in Patient Care Solutions. Organic orders grew 4%, with backlog totaling $23.7 billion.
Operating cash flow reached $907 million, including a $55 million tariff refund.
The company now expects adjusted earnings of $4.95 to $5.05 per share for 2026, compared with $4.80 to $5.00 previously. Adjusted earnings and organic growth are supplemental, non-GAAP measures. The outlook remains a company projection.
Sources: GE HealthCare earnings release, distributed by Business Wire.